A followup to our NASH Market Research from 2018.
Research Objectives:
-
Understand the current Nonalcoholic steatohepatitis (NASH) treatment landscape and areas of unmet need
-
Explore what physicians know about the current state of affairs in the NASH market and pipeline and what physicians anticipate for the future of NASH treatment
Methodology:
Method: 10-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, US Hepatologists
Sample Size: n=54
Fielding Period: March 6-7, 2019
One key finding:
- Physicians treat over 30 NASH patients in a typical month and are generally aware of treatments in development for NASH.
- They are diagnosing these patients using mostly blood tests and ultrasounds and sometimes use transient elastography, liver biopsy, and CT scan
Download the full report now!